CA1017675A - Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide - Google Patents

Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide

Info

Publication number
CA1017675A
CA1017675A CA166,764A CA166764A CA1017675A CA 1017675 A CA1017675 A CA 1017675A CA 166764 A CA166764 A CA 166764A CA 1017675 A CA1017675 A CA 1017675A
Authority
CA
Canada
Prior art keywords
prolyl
disease
treat parkinson
glycine amide
leucyl glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA166,764A
Other languages
English (en)
Other versions
CA166764S (en
Inventor
Nicholas P. Plotnikoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of CA1017675A publication Critical patent/CA1017675A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA166,764A 1972-12-26 1973-03-22 Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide Expired CA1017675A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31814272A 1972-12-26 1972-12-26

Publications (1)

Publication Number Publication Date
CA1017675A true CA1017675A (fr) 1977-09-20

Family

ID=23236838

Family Applications (1)

Application Number Title Priority Date Filing Date
CA166,764A Expired CA1017675A (fr) 1972-12-26 1973-03-22 Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide

Country Status (2)

Country Link
US (1) US3795738A (fr)
CA (1) CA1017675A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931184A (en) * 1974-10-31 1976-01-06 Abbott Laboratories Purification method for prolyl-leucylglycinamide
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
IL154318A (en) * 2003-02-06 2010-05-31 Sarah Herzog Memorial Hospital Pharmaceutical compositions for the treatment of movement disorders
EP2187910A2 (fr) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Utilisation de band 3 protein (824-829) et/ou melanocyte-stimulating hormone release-inhibiting factor en tant qu'agent thérapeutique pour le traitement d'infection par pseudomonas aeruginosa
EP2197463A2 (fr) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG UTILISATION DU PEPTIDE RGDSPASSKP ET OPTIONNELLEMENT DE L'ANGIOTENSIN iI COMME AGENT THERAPEUTIQUE, P.E. POUR LE TRAITEMENT DES INFECTIONS DE S. PNEUMONIAE& xA;

Also Published As

Publication number Publication date
US3795738A (en) 1974-03-05

Similar Documents

Publication Publication Date Title
BR7202331D0 (pt) Conjunto de eletrodo implantavel no tecido do corpo
BR7307049D0 (pt) Composicao de materia estimulante dos detectores de frio do corpo humano
NL188078B (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
AU501501B2 (en) Tissue stimulation unit
DE3070545D1 (en) Bonding compositions to the hard tissue of human body
FR2282259A1 (fr) Medicament sous forme de grains friables
BE816683A (fr) Masseur therapeutique corporel
FR2299853A1 (fr) Bandage therapeutique pour l'administration de scopolamine par voie percutanee
CA1017675A (fr) Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide
GB1370973A (en) Therapeutic compositions
ZA72423B (en) Improvements in or relating to the treatment of diseases of the skin or mucosa
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
FR2303535A1 (fr) Peptides de l-3-(3,4-dihydroxyphenyl) 2-methylalanine et leur procede de preparation
PH11010A (en) Therapeutic composition for the treatment of mycobacterioses and method of use thereof
SU564863A1 (ru) Устройство дл ходьбы больного
PH10473A (en) Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
JPS56108771A (en) Benzimidazoline salt and application to agricultural drug
CA1019740A (fr) Derives de l'amino propanediol, leur procede de preparation et leurs applications en therapeutique humaine
IT7235774U1 (it) Dispositivo per l'applicazione diretta di sostanze medicinali nelle cavita' corporee ad esempio l'utero
CA964582A (en) Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
PH12325A (en) Method of using l-prolyl l-leucyl glycine amide as anti-depressant
ZA715494B (en) Treatment of parkinson's disease
CA989731A (en) Treatment of heart diseases
JPS5270589A (en) Living body stimulating device
JPS5275083A (en) Living body stimulating device